Introduction
The proto-oncogene, c-Jun is a component of the transcription factor AP-1, and plays a key role in a variety of cellular processes including growth, proliferation, transformation and apoptosis (Shaulian and Karin, 2002) . In tumorigenic processes, cellular transformation and malignancy induced by Ha-Ras require c-Jun transactivation activity , and overexpression of c-Jun is sufficient to induce transformation of immortalized rat fibroblast cell line, Rat1a (Schutte et al., 1989) . Additionally, c-Jun is also involved in angiogenesis, invasion and metastasis (Jochum et al., 2001) . Aberrant expression and increased transactivation activity of c-Jun are observed in a wide spectrum of human cancers (Eferl and Wagner, 2003) . It is well accepted that UV radiation exposure induces activation of Jun N-terminal kinase, which leads to N-terminus phosphorylation of c-Jun and enhances c-Jun transactivation activity (Karin, 1995) . On the other hand, the phosphorylation of c-Jun C-terminus by GSK3 or CKII decreases the activities of DNA-binding and Sp1 protein interaction (Boyle et al., 1991; Lin et al., 1992; Chen et al., 2007) . Recently, we identified that CaN is involved in the dephosphorylation of c-Jun C-terminus at Ser-243, and this modification increases the interaction between c-Jun and Sp1, which results in the enhancement of c-Jun-regulated gene transcription (Chen et al., 2007) .
Calcineurin (CaN) is a heterodimer composed of the catalytic/calmodulin (CaM)-binding subunit A (CnA) and the calcium-binding regulatory subunit B (CnB). It is ubiquitously expressed in mammalian tissues and is particularly abundant in the brain (Klee et al., 1988) . CaN participates in Ca 2 þ -dependent signal transduction and numerous other cellular functions. (Rusnak and Mertz, 2000; Kahl and Means, 2003) . There has been some evidence indicating that CaN may be involved in tumorigenesis. In mitochondrial DNA-depleted human lung carcinoma A549 cells, the cell morphology is altered while invasive behavior and the increased expression and activity of CaN could be observed (Amuthan et al., 2002) . In addition, higher levels of CaN protein and activity are observed in human colorectal adenocarcinomas and neuronal tumors (Goto et al., 1987; Lakshmikuttyamma et al., 2005) . However, information regarding the mechanism in which CaN-overexpression causes the formation of human tumors has been limited.
In this study, we confirm that CaN interacts with c-Jun in living cells through the CaM-binding domain of CnA. The c-Jun-S243A mutant was more stable than wild-type c-Jun and knocking down endogenous CaN expression by siRNA decreased the half-life of wild-type c-Jun protein.
These results suggest that CaN first interacts with c-Jun and then dephosphorylates c-Jun at Ser-243 to enhance the stability of c-Jun. In soft agar assay, knocking down endogenous CaN expression decreased c-Jun-induced cell transformation activity. Furthermore, increased CaN and c-Jun protein levels accompanied by decreased Ser-243 phosphorylation of c-Jun in tissue samples from cervical cancer patients were observed, consistent with results obtained from cell culture experiments. These findings provide a novel signaling pathway as well as cellular function of CaN in maintaining the stability of c-Jun, which enhances cell proliferation and transformation.
Results

Calcineurin interacts with c-Jun within living cells
Overexpression of active CaN (AI domain-deletion of CnA) decreases c-Jun phosphorylation at Ser-243 (Chen et al., 2007) . Consistent with our previous result, inhibition of endogenous CaN with siRNA led to increased Ser-243 phosphorylation of c-Jun (Figure 1a) , which further verified that CaN targets c-Jun at Ser-243. Using immunoprecipitation and GST-pull down assays, CaN interacts with the phosphorylated c-Jun C-terminus in vitro (Chen et al., 2007) . Based on these observations, we determined whether the interaction between these two proteins occurred in the living cell by coexpressing CFPtagged wild-type CnA with YFP-tagged c-Jun. Immunofluorescence microscopy revealed the codistribution of CFP-wt-CnA and YPF-c-Jun in the cell nucleus ( Figure 1b) . To determine whether their colocalization was due to direct interaction, FRET was performed in these cells (Miyawaki et al., 1997; see Supplementary Materials) . If two proteins are within 50 Å to each other, therefore suggesting direct interaction, the energy would be transferred from an excited CFP donor to YFP acceptor and create a FRET emission signal (Figure 1c) . The equation used here is FRET C (see Supplementary Materials), which is resulted from subtracting the background of CFP and YFP from raw FRET. We found that the FRET C image of cells coexpressing CFP-wt-CnA and YFP-c-Jun was observed in the cell nucleus whereas no FRET C image in the cells coexpressing CFP and YFPtag was observed (Figure 1d ). These results indicated that CnA and c-Jun interacted directly in the cell nucleus. The CFP/YFP or CFP-wt-CnA/YFP-c-Jun fluorescent intensity values of FRET C and FRETN C are shown in Table 1 . The FRET C and FRETN C values of CFP-wt-CnA/YFPc-Jun were positive which indicated that the interaction between CFP-wt-CnA and YFP-c-Jun, but not CFP and YFP, was detected in the nucleus.
Calmodulin-binding domain of CnA is required for binding to c-Jun Phosphorylated C-terminus of c-Jun has been identified as the interactive domain for CnA (Chen et al., 2007) , but the specific domain within CnA involved in this interaction has not been described. To pursue this further, expression vectors bearing various CFP-tagged deletion mutants of CnA ( Figure 2a ) combined with YFP-tagged c-Jun were cotransfected into cells and analysed by FRET assay. Only cells cotransfected with the C-terminal deletion mutant of CnA (CFP-CnA-CAT) and YFP-c-Jun lost the FRET images (Figure 2b ), which indicated that the c-Juninteraction region was located in the C-terminus of CnA. Next, the precise c-Jun-interaction region was analysed with cell lysates expressing a series of C-terminal deletion mutants of CnA by glutathione S-transferase (GST) pulldown assay (Figure 2a ). Comparing the binding activities of c-Jun with CnA-DAI and CnA-DAI-CaM, the latter did not bind to c-Jun, which demonstrates the critical role of CaM-binding domain in CaN/c-Jun interaction CaN-mediated Ser-243 dephosphorylation of c-Jun stabilizes the c-Jun protein stability Previously, it has been reported that phosphorylation of c-Jun at Thr-239 and Ser-243 targets c-Jun for polyubiquitination and degradation, and the v-Jun point mutation on Ser-243 allows c-Jun to escape GSK3-dependent recognition and destruction by the E3 ligase (Wei et al., 2005) . Additionally, we identified the phosphatase that dephosphorylates Ser-243 of c-Jun is CaN (Chen et al., 2007) . We next determined whether CaN participates in regulating c-Jun protein stability through Ser-243 dephosphorylation of c-Jun. Consistent with the previous study (Wei et al., 2005) , the half-life of the wild-type c-Jun protein was shorter than that of c-Jun-S243A ( Figure 4a Increased CaN parallels with c-Jun expression in cervical cancers CaN could stabilize c-Jun through dephosphorylating Ser-243 in this study, and c-Jun is able to inducing cell transformation when overexpressed in chicken embryonic fibroblasts (Bos et al., 1990) . However, the correlation between CaN and c-Jun protein expressions in cancer cells is unavailable. Therefore, the CaN and c-Jun protein levels were examined in the cervical tissue samples obtained from 15 patients with cervical cancer. We found that 7 out of 15 samples (46.6%) exhibited enhanced CaN, as well as c-Jun expressions, many of which were diagnosed as squamous cell carcinoma (Figures 5a-c) .
These results suggested that high expression of CaN might lead to prolonged c-Jun protein stability in c-Jun overexpressed malignant squamous carcinomas. To further correlate this with the hypothesis that CaN mediates dephosphorylation of c-Jun-Ser-243 to enhance c-Jun stability, the expression levels of phospho-Ser-243 of c-Jun were detected by specific p-Ser-243 antibody in the 7 samples (Figure 5a ). We found that the Ser-243 phosphorylation levels were relatively lower in the tumor part (Figure 5d ). The reason for the enhanced dephosphorylation on Ser-243 of c-Jun in cervical cancer could have resulted, at least in part, from the increased expression of CaN, which led to prolonged half-life of c-Jun proteins in human cervical cancers. In the rest of the samples (Figure 5f , no. 8-15), which were mostly identified as adenocarcinoma cervical cancer, the CaN expression was not positively proportional to c-Jun expression (Figures 5f-h) . The approximately equal CaN expression levels between normal and tumorous parts with less c-Jun expression in the tumorous parts were observed, indicating that c-Jun may not be the major regulator of tumor progression in these cervical cancer patients. GSK3 is known to regulate c-Jun-mediated cell cycle progression by altering the half-life of c-Jun through Ser-239/243 phosphorylation (Wei et al., 2005) . However, whether the GSK3-mediated attenuation of c-Jun protein stability correlated to the c-Jun oncogenic ability is still not clear. If GSK3 played a functional role in c-Junmediated tumorigenesis in most squamous cervical carcinoma (Figure 5a ), GSK3 activity would be attenuated in order to lower the phosphorylation of c-Jun C-terminus. However, as shown in Figure 5e , increased GSK3 activity was observed which indicated that the GSK3 activity was not positively correlated to c-Junmediated tumorigenesis. Taken together, our results support the notion that CaN instead of GSK3 played a more important role in maintaining c-Jun stability in most squamous cervical carcinoma.
CaN-mediated Ser-243 dephosphorylation of c-Jun is correlated to c-Jun-mediated cell transformation
Since the positive correlation between CaN-mediated c-Jun dephosphorylation and overexpression was observed in cervical cancer patients, we next examined the mechanism by which CaN regulates c-Jun-mediated tumorigenesis. To demonstrate that CaN-mediated c-Jun stability was important for cell transformation, soft agar assay was performed by exogenous overexpression of c-Jun or c-Jun-S243A accompanying the treatment of CaN siRNA. When CaN level was diminished by siRNA, the enhanced colonies formation induced by c-Jun was subsided (Figure 6a ). In addition, the colony size and numbers induced by c-Jun became smaller and the cell proliferation rate was decreased when endogenous CaN was knocked down by CaN siRNA ( Figures 6b and c) . Conversely, the rate of cell proliferation, colony numbers and size of c-Jun-S243A transfectants were attenuated slightly when CaN levels were inhibited (Figures  6a-c) . Collectively, these results indicate that CaN-mediated increase in c-Jun protein stability occurs through targeting the Ser-243 of c-Jun, resulting in the enhancement of colonies formation.
Discussion
CaN is important in regulating various physiological cellular functions in higher eukaryotic organisms (Rusnak and Mertz, 2000) and the substrates of CaN are tightly controlled in the activation of the cellular function by CaN-mediated signals. Here, we identified c-Jun as a substrate of CaN and this interaction occurs through the CaM-binding domain within CnA (Figure 3a) . It is known that both CnB and Ca 2 þ /CaM are important to activate phosphatase activity of CaN (Klee et al., 1988) , but here we found that CaM could compete for the binding of c-Jun to CaN (Figure 3b ). According to previous report, CnB alone, but not CaM, is able to activate the phosphatase activity of CaN by about 10-fold, and synergistic activation can be observed when CnA interacts with both CnB and Ca 2 þ /CaM (Hou et al., 2004) . Therefore, we speculate that CnB may compensate for the partial loss of CaN activity as a result of the competitive binding between CaM and c-Jun to CaN.
The C-terminal region closed to the DNA-binding domain (residues 227-252) on c-Jun is dephosphorylated in phorbol ester-treated human osteosarcoma MG63 cells (Boyle et al., 1991) . Therefore, Thr-239 or Ser-249 may also be dephosphorylation targets of CaN. The protein stability of individual mutants of Thr-239A, Ser-243A and Ser-249A was compared to the wild-type c-Jun. All the mutant c-Jun showed increased protein stability, among which the Ser-243A mutant showed the most prolonged half-life (Supplementary Figure S1) . Although whether Thr-239 and Ser-249 of c-Jun are dephosphorylated by CaN still needs to be clarified, we confirmed that the dephosphorylation of Ser-243 by CaN enhanced c-Jun stability.
Although c-Jun-S243A (or S243F) mutant causes a minor increase in cell transformation according to the soft agar assay (Figure 6 ; Bos et al., 1990; Wei et al., 2005) , this mutant is sufficient to promote tumorigenesis in chicken embryo (Wong et al., 1992) . We found that silencing CaN significantly reduced c-Jun activity, including transformation and proliferation, but the same effects were obscured in cells overexpressing c-Jun-S243A mutant (Figure 6 ). Furthermore, a positive correlation was observed between the expression levels of CaN and c-Jun, which could be a result of the decreased phosphoSer-243 of c-Jun in most of the squamous carcinomas (Figures 5a-d) . However, c-Jun expression patterns were very different between adenocarcinomas (Figure 5f ) and squamous carcinomas (Figure 5a) , indicating that the different types of cervical cancer may result from diverse oncogenic mechanism. Based on our findings, we suggest that CaN levels and the dephosphorylation status of c-Jun Ser-243 might serve as useful indicators for detection and therapeutic targets of human cervical cancers, particularly in squamous cell carcinomas.
The phosphorylation state of c-Jun will coordinate with external signal-induced c-Jun overexpression to control the cell fate. Dephosphorylation of the c-Jun Cterminus by CaN increases its DNA-binding affinity and protein stability which opposites the effect of GSK3. However, the influence of GSK3 activity on c-Junmediated tumor formation has not been elucidated. Since GSK3 is inactivated via the phosphorylation of Ser-21 (GSK3A) and Ser-9 (GSK3B) (Doble and Woodgett, 2003) , we identify the relative activity of GSK3 in these cervical cancer patients with higher c-Jun and CaN protein expression (Figure 5a) . Surprisingly, the increased GSK3 activity was observed in the malignant part, which suggested that GSK3 activity does not participate in the higher c-Jun expression in tumor formation (Figure 5e ). Although both CaN and GSK3 were able to affect the c-Jun stability, our results support the notion that CaN plays a more critical role than GSK3 in maintaining the stability of c-Jun in human cervical cancer. In a recent clinical trial, inhibition of calcineurin activity by CsA and FK506 in human urinary bladder cancer cells was shown to enhance the sensitivity of tumor cells to taxol-induced apoptotic effect (Nomura et al., 2002) . However, CsA is not a suitable tumor therapeutic agent due to its immunosuppressing effect, which may lead to an enhancement of tumor progression. Therefore the CaN/c-Jun pathway might be a possible new target for the usage of cancer therapeutics.
Taken together, an increased GSK3 activity could not fully account for c-Jun stability in squamous cervical cancer formation and we provided evidence to show that c-Jun-induced cell transformation could result from the increase expression of CaN. The half-life of c-Jun proteins was therefore increased by CaN that results in high expression of c-Jun, followed by the enhancement of tumor formation.
Materials and methods
Cell culture and transfection 293T, HeLa and COS-7 cells were grown at 37 1C under 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 mg ml À1 streptomycin and penicillin (Gibco BRL, Grand Island, NY, USA). Transient transfection was done by Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. HeLa or 293T cell line stably expressed c-Jun or c-Jun-S243A mutant were cloned as previously described (Chen et al., 2007) .
Cervical cancer samples
The cervical tissues from 15 cervical cancer patients following the principle of Experiment and Ethics Committee were pathologically assessed and surgically resected at National Cheng Kung University Hospital. Fourteen of them were categorized in stage Ib and the other one was in stage IIa. Seven of them were cervical adenocarcinoma and the rest patients were classified as squamous cell carcinoma. Tissue samples were homogenized in the lysis buffer (20 mM HEPES-KOH (pH 7.9), 150 mM NaCl, 0.5% NP-40 and protease inhibitor) and 50 mg of proteins were analysed by western blotting.
Immunoprecipitation
Transfected cells were lysed with lysis buffer as mentioned above. Cell lysates (500 mg) were incubated with anti-c-Jun antibody or anti-Myc antibody-conjugated agarose (Santa Cruz, Santa Cruz, CA, USA; Upstate Biotechnology, Lake Placid, NY, USA) in the immunoprecipitation buffer (20 mM HEPES-KOH (pH 7.9), 150 mM NaCl, 2 mM MgCl 2 , 0.1 mM KCl, 10% glycerol and protease inhibitor) at 4 1C overnight. The immunecomplexes were washed three times with wash buffer (immunoprecipitation buffer containing 0.5% NP-40). Western blotting was performed and analysed by specific antibodies.
GST pull-down assay Purified GST-c-Jun (1 mg) (see Supplementary Materials) was phosphorylated by in vitro GSK3B assay (Chen et al., 2007) . The Sepharose-conjugated nonphosphorylated c-Jun was prepared in the same procedure except the kinase reaction. 293T cell lysates (500 mg) expressing different CFP-CnA deletion mutants or purified CaN protein containing CnA and CnB subunits and CaM (Biomol, International, Plymouth Meeting, PA, USA) were incubated with the beads containing GST-p-cJun or GST-c-Jun in binding buffer (20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 6 mM MgCl 2 , 1.5 mM CaCl 2 and protease inhibitor) at 37 1C for 30 min. After washing twice with wash buffer (binding buffer with 0.5% NP-40), the samples were separated by SDS-PAGE and detected by indicated antibodies. CFP-CnA deletion mutants were detected by JL-8 antibody (BD Biosciences, Franklin Lakes, NJ, USA).
Protein degradation and polyubiquitination assays
HeLa or 293T cells were first transiently transfected with indicated siRNA oligonucleotide (see Supplementary Materials) for 24 h and pcDNA3-Myc-c-Jun or pcDNA3-Myc-c-Jun-S243A (Chen et al., 2007) were then transfected into these transfectants for another 24 h. These cells were treated with cycloheximide (200 mg ml
À1
; Sigma, Saint Quentin Fallavier, France) and lysed at indicated time points. In ubiquitination assay, 293T cells transfectants were treated with 30 mM MG132 (Tocris, Bioscience, Ellisville, MI, USA) for 6 h, and 1 mg of cell lysates was incubated with anti-Myc antibody-conjugated agarose (Upstate) at 4 1C overnight, washed twice with wash buffer and analysed by western blotting with specific antibodies.
Cell proliferation and soft agar assays 0.3% agarose (1 ml) in complete growth medium containing 3 Â 10 4 HeLa or 293T cells stably expressing c-Jun or c-Jun-S243A mutant with indicated siRNA oligonucleotides was seeded onto 1.5 ml of 0.6% agarose in six-well plates for 14-21 days, and the colonies were photographed and scored for statistic analysis. In cell proliferation assay, 3 Â 10 4 293T cells transiently transfected with indicated plasmids were seeded onto 12-well plates and counted two days after seeding.
CFP/YFP FRET microscopy and image analysis
For FRET analysis in living cells, COS7 cells were transfected with the indicated plasmids on 35-mm round glass coverslips for 24-48 h. The CFP and YFP fluorescence were examined with FV-1000 imaging system (Olympus, Tokyo, Japan) equipped with objective lens UPlanApo Â 60 oil and FV-10 software (FV1000 version 1 application software). Optional 440 nm and 515 nm LD lasers were used to directly excite CFP and YFP, and the emission spectra of CFP and YFP were 470-500 and 535-565 nm, respectively. Three images were acquired for measuring FRET and the equation used here is represented to correct FRET (FRET C ). Detail descriptions are available in Supplementary Materials.
